Comprehensive, Evidence-Based Update on Disease-Modifying Therapies (DMTs) and Symptom Management in Multiple Sclerosis: A Clinical Overview for Physicians

I. Disease-Modifying Therapy (DMT) Indications & Goals Multiple sclerosis (MS) remains an immune-mediated demyelinating disease of the central nervous system

Comprehensive, Evidence-Based Update on Disease-Modifying Therapies (DMTs) and Symptom Management in Multiple Sclerosis: A Clinical Overview for Physicians Read More »

Comprehensive Review of Thalassemia: Pathophysiology, Classification, Diagnosis, Management, and Emerging Therapies—An Evidence-Based Update for Hematologists

Authored for the Hematology Community | Updated in Accordance with 2023–2024 Guidelines (ASH, EHA, WFH, NICE, Thalassaemia International Federation) 1.

Comprehensive Review of Thalassemia: Pathophysiology, Classification, Diagnosis, Management, and Emerging Therapies—An Evidence-Based Update for Hematologists Read More »